Skip to main content
Erschienen in: Acta Neuropathologica 4/2011

01.04.2011 | Original Paper

Perivascular drainage of solutes is impaired in the ageing mouse brain and in the presence of cerebral amyloid angiopathy

verfasst von: Cheryl A. Hawkes, Wolfgang Härtig, Johannes Kacza, Reinhard Schliebs, Roy O. Weller, James A. Nicoll, Roxana O. Carare

Erschienen in: Acta Neuropathologica | Ausgabe 4/2011

Einloggen, um Zugang zu erhalten

Abstract

The deposition of amyloid-β (Aβ) peptides in the walls of leptomeningeal and cortical blood vessels as cerebral amyloid angiopathy (CAA) is present in normal ageing and the majority of Alzheimer’s disease (AD) brains. The failure of clearance mechanisms to eliminate Aβ from the brain contributes to the development of sporadic CAA and AD. Here, we investigated the effects of CAA and ageing on the pattern of perivascular drainage of solutes in the brains of naïve mice and in the Tg2576 mouse model of AD. We report that drainage of small molecular weight dextran along cerebrovascular basement membranes is impaired in the hippocampal capillaries and arteries of 22-month-old wild-type mice compared to 3- and 7-month-old animals, which was associated with age-dependent changes in capillary density. Age-related alterations in the levels of laminin, fibronectin and perlecan in vascular basement membranes were also noted in wild-type mice. Furthermore, dextran was observed in the walls of veins of Tg2576 mice in the presence of CAA, suggesting that deposition of Aβ in vessel walls disrupts the normal route of elimination of solutes from the brain parenchyma. These data support the hypothesis that perivascular solute drainage from the brain is altered both in the ageing brain and as a consequence of CAA. These findings have implications for the success of therapeutic strategies for the treatment of AD that rely upon the health of the ageing cerebral vasculature.
Literatur
1.
Zurück zum Zitat Ailles L, Kisilevsky R, Young ID (1993) Induction of perlecan gene expression precedes amyloid formation during experimental murine AA amyloidogenesis. Lab Investig 69:443–448PubMed Ailles L, Kisilevsky R, Young ID (1993) Induction of perlecan gene expression precedes amyloid formation during experimental murine AA amyloidogenesis. Lab Investig 69:443–448PubMed
2.
Zurück zum Zitat Akima M, Nonaka H, Kagesawa M, Tanaka K (1986) A study on the microvasculature of the cerebral cortex. Fundamental architecture and its senile change in the frontal cortex. Lab Investig 55:482–489PubMed Akima M, Nonaka H, Kagesawa M, Tanaka K (1986) A study on the microvasculature of the cerebral cortex. Fundamental architecture and its senile change in the frontal cortex. Lab Investig 55:482–489PubMed
3.
Zurück zum Zitat Aumailley M, Krieg T (1996) Laminins: a family of diverse multifunctional molecules of basement membranes. J Investig Dermatol 106:209–214PubMedCrossRef Aumailley M, Krieg T (1996) Laminins: a family of diverse multifunctional molecules of basement membranes. J Investig Dermatol 106:209–214PubMedCrossRef
4.
Zurück zum Zitat Bell RD, Zlokovic BV (2009) Neurovascular mechanisms and blood–brain barrier disorder in Alzheimer’s disease. Acta Neuropathol 118:103–113PubMedCrossRef Bell RD, Zlokovic BV (2009) Neurovascular mechanisms and blood–brain barrier disorder in Alzheimer’s disease. Acta Neuropathol 118:103–113PubMedCrossRef
5.
Zurück zum Zitat Boche D, Zotova E, Weller RO, Love S, Neal JW, Pickering RM et al (2008) Consequence of Aβ immunization on the vasculature of human Alzheimer’s disease brain. Brain 131:3299–3310PubMedCrossRef Boche D, Zotova E, Weller RO, Love S, Neal JW, Pickering RM et al (2008) Consequence of Aβ immunization on the vasculature of human Alzheimer’s disease brain. Brain 131:3299–3310PubMedCrossRef
6.
Zurück zum Zitat Bradbury MW, Cserr HF, Westrop RJ (1981) Drainage of cerebral interstitial fluid into deep cervical lymph of the rabbit. Am J Physiol 240:F329–F336PubMed Bradbury MW, Cserr HF, Westrop RJ (1981) Drainage of cerebral interstitial fluid into deep cervical lymph of the rabbit. Am J Physiol 240:F329–F336PubMed
7.
Zurück zum Zitat Bronfman FC, Alvarez A, Morgan C, Inestrosa NC (1998) Laminin blocks the assembly of wild-type Aβ and the Dutch variant peptide into Alzheimer’s fibrils. Amyloid 5:16–23PubMedCrossRef Bronfman FC, Alvarez A, Morgan C, Inestrosa NC (1998) Laminin blocks the assembly of wild-type Aβ and the Dutch variant peptide into Alzheimer’s fibrils. Amyloid 5:16–23PubMedCrossRef
8.
Zurück zum Zitat Bronfman FC, Garrido J, Alvarez A, Morgan C, Inestrosa NC (1996) Laminin inhibits amyloid-beta-peptide fibrillation. Neurosci Lett 218:201–203PubMedCrossRef Bronfman FC, Garrido J, Alvarez A, Morgan C, Inestrosa NC (1996) Laminin inhibits amyloid-beta-peptide fibrillation. Neurosci Lett 218:201–203PubMedCrossRef
9.
Zurück zum Zitat Burger S, Noack M, Kirazov LP, Kirazov EP, Naydenov CL, Kouznetsova E et al (2009) Vascular endothelial growth factor (VEGF) affects processing of amyloid precursor protein and beta-amyloidogenesis in brain slice cultures derived from transgenic Tg2576 mouse brain. Int J Dev Neurosci 27:517–523PubMedCrossRef Burger S, Noack M, Kirazov LP, Kirazov EP, Naydenov CL, Kouznetsova E et al (2009) Vascular endothelial growth factor (VEGF) affects processing of amyloid precursor protein and beta-amyloidogenesis in brain slice cultures derived from transgenic Tg2576 mouse brain. Int J Dev Neurosci 27:517–523PubMedCrossRef
10.
Zurück zum Zitat Burns EM, Kruckeberg TW, Gaetano PK (1981) Changes with age in cerebral capillary morphology. Neurobiol Aging 2:283–291PubMedCrossRef Burns EM, Kruckeberg TW, Gaetano PK (1981) Changes with age in cerebral capillary morphology. Neurobiol Aging 2:283–291PubMedCrossRef
11.
Zurück zum Zitat Calhoun ME, Burgermeister P, Phinney AL, Stalder M, Tolnay M, Wiederhold KH et al (1999) Neuronal overexpression of mutant amyloid precursor protein results in prominent deposition of cerebrovascular amyloid. Proc Natl Acad Sci USA 96:14088–14093PubMedCrossRef Calhoun ME, Burgermeister P, Phinney AL, Stalder M, Tolnay M, Wiederhold KH et al (1999) Neuronal overexpression of mutant amyloid precursor protein results in prominent deposition of cerebrovascular amyloid. Proc Natl Acad Sci USA 96:14088–14093PubMedCrossRef
12.
Zurück zum Zitat Carare RO, Bernardes-Silva M, Newman TA, Page AM, Nicoll JA, Perry VH et al (2008) Solutes, but not cells, drain from the brain parenchyma along basement membranes of capillaries and arteries: significance for cerebral amyloid angiopathy and neuroimmunology. Neuropathol Appl Neurobiol 34:131–144PubMedCrossRef Carare RO, Bernardes-Silva M, Newman TA, Page AM, Nicoll JA, Perry VH et al (2008) Solutes, but not cells, drain from the brain parenchyma along basement membranes of capillaries and arteries: significance for cerebral amyloid angiopathy and neuroimmunology. Neuropathol Appl Neurobiol 34:131–144PubMedCrossRef
13.
Zurück zum Zitat Castillo GM, Ngo C, Cummings J, Wight TN, Snow AD (1997) Perlecan binds to the beta-amyloid proteins (Aβ) of Alzheimer’s disease, accelerates Aβ fibril formation, and maintains Aβ fibril stability. J Neurochem 69:2452–2465PubMedCrossRef Castillo GM, Ngo C, Cummings J, Wight TN, Snow AD (1997) Perlecan binds to the beta-amyloid proteins (Aβ) of Alzheimer’s disease, accelerates Aβ fibril formation, and maintains Aβ fibril stability. J Neurochem 69:2452–2465PubMedCrossRef
14.
Zurück zum Zitat Christie R, Yamada M, Moskowitz M, Hyman B (2001) Structural and functional disruption of vascular smooth muscle cells in a transgenic mouse model of amyloid angiopathy. Am J Pathol 158:1065–1071PubMedCrossRef Christie R, Yamada M, Moskowitz M, Hyman B (2001) Structural and functional disruption of vascular smooth muscle cells in a transgenic mouse model of amyloid angiopathy. Am J Pathol 158:1065–1071PubMedCrossRef
15.
Zurück zum Zitat Chung YA, O JH, Kim JY, Kim KJ, Ahn KJ (2009) Hypoperfusion and ischemia in cerebral amyloid angiopathy documented by 99mTc-ECD brain perfusion SPECT. J Nucl Med 50:1969–1974PubMedCrossRef Chung YA, O JH, Kim JY, Kim KJ, Ahn KJ (2009) Hypoperfusion and ischemia in cerebral amyloid angiopathy documented by 99mTc-ECD brain perfusion SPECT. J Nucl Med 50:1969–1974PubMedCrossRef
16.
Zurück zum Zitat Costell M, Gustafsson E, Aszodi A, Morgelin M, Bloch W, Hunziker E et al (1999) Perlecan maintains the integrity of cartilage and some basement membranes. J Cell Biol 147:1109–1122PubMedCrossRef Costell M, Gustafsson E, Aszodi A, Morgelin M, Bloch W, Hunziker E et al (1999) Perlecan maintains the integrity of cartilage and some basement membranes. J Cell Biol 147:1109–1122PubMedCrossRef
17.
Zurück zum Zitat Cotman SL, Halfter W, Cole GJ (2000) Agrin binds to beta-amyloid (Aβ), accelerates Aβ fibril formation, and is localized to Aβ deposits in Alzheimer’s disease brain. Mol Cell Neurosci 15:183–198PubMedCrossRef Cotman SL, Halfter W, Cole GJ (2000) Agrin binds to beta-amyloid (Aβ), accelerates Aβ fibril formation, and is localized to Aβ deposits in Alzheimer’s disease brain. Mol Cell Neurosci 15:183–198PubMedCrossRef
18.
Zurück zum Zitat Couchman JR, Abrahamson DR, McCarthy KJ (1993) Basement membrane proteoglycans and development. Kidney Int 43:79–84PubMedCrossRef Couchman JR, Abrahamson DR, McCarthy KJ (1993) Basement membrane proteoglycans and development. Kidney Int 43:79–84PubMedCrossRef
19.
Zurück zum Zitat Deane R, Zlokovic BV (2007) Role of the blood–brain barrier in the pathogenesis of Alzheimer’s disease. Curr Alzheimer Res 4:191–197PubMedCrossRef Deane R, Zlokovic BV (2007) Role of the blood–brain barrier in the pathogenesis of Alzheimer’s disease. Curr Alzheimer Res 4:191–197PubMedCrossRef
20.
Zurück zum Zitat Domnitz SB, Robbins EM, Hoang AW, Garcia-Alloza M, Hyman BT, Rebeck GW et al (2005) Progression of cerebral amyloid angiopathy in transgenic mouse models of Alzheimer disease. J Neuropathol Exp Neurol 64:588–594PubMed Domnitz SB, Robbins EM, Hoang AW, Garcia-Alloza M, Hyman BT, Rebeck GW et al (2005) Progression of cerebral amyloid angiopathy in transgenic mouse models of Alzheimer disease. J Neuropathol Exp Neurol 64:588–594PubMed
21.
Zurück zum Zitat Erickson AC, Couchman JR (2000) Still more complexity in mammalian basement membranes. J Histochem Cytochem 48:1291–1306PubMed Erickson AC, Couchman JR (2000) Still more complexity in mammalian basement membranes. J Histochem Cytochem 48:1291–1306PubMed
22.
Zurück zum Zitat Haglund M, Kalaria R, Slade JY, Englund E (2006) Differential deposition of amyloid beta peptides in cerebral amyloid angiopathy associated with Alzheimer’s disease and vascular dementia. Acta Neuropathol 111:430–435PubMedCrossRef Haglund M, Kalaria R, Slade JY, Englund E (2006) Differential deposition of amyloid beta peptides in cerebral amyloid angiopathy associated with Alzheimer’s disease and vascular dementia. Acta Neuropathol 111:430–435PubMedCrossRef
23.
Zurück zum Zitat Han BH, Zhou ML, Abousaleh F, Brendza RP, Dietrich HH, Koenigsknecht-Talboo J et al (2008) Cerebrovascular dysfunction in amyloid precursor protein transgenic mice: contribution of soluble and insoluble amyloid-beta peptide, partial restoration via gamma-secretase inhibition. J Neurosci 28:13542–13550PubMedCrossRef Han BH, Zhou ML, Abousaleh F, Brendza RP, Dietrich HH, Koenigsknecht-Talboo J et al (2008) Cerebrovascular dysfunction in amyloid precursor protein transgenic mice: contribution of soluble and insoluble amyloid-beta peptide, partial restoration via gamma-secretase inhibition. J Neurosci 28:13542–13550PubMedCrossRef
24.
Zurück zum Zitat Hicks P, Rolsten C, Brizzee D, Samorajski T (1983) Age-related changes in rat brain capillaries. Neurobiol Aging 4:69–75PubMedCrossRef Hicks P, Rolsten C, Brizzee D, Samorajski T (1983) Age-related changes in rat brain capillaries. Neurobiol Aging 4:69–75PubMedCrossRef
25.
Zurück zum Zitat Hooijmans CR, Graven C, Dederen PJ, Tanila H, van Groen T, Kiliaan AJ (2007) Amyloid beta deposition is related to decreased glucose transporter-1 levels and hippocampal atrophy in brains of aged APP/PS1 mice. Brain Res 1181:93–103PubMedCrossRef Hooijmans CR, Graven C, Dederen PJ, Tanila H, van Groen T, Kiliaan AJ (2007) Amyloid beta deposition is related to decreased glucose transporter-1 levels and hippocampal atrophy in brains of aged APP/PS1 mice. Brain Res 1181:93–103PubMedCrossRef
26.
Zurück zum Zitat Hutchins PM, Lynch CD, Cooney PT, Curseen KA (1996) The microcirculation in experimental hypertension and aging. Cardiovasc Res 32:772–780PubMed Hutchins PM, Lynch CD, Cooney PT, Curseen KA (1996) The microcirculation in experimental hypertension and aging. Cardiovasc Res 32:772–780PubMed
27.
Zurück zum Zitat Ichimura T, Fraser PA, Cserr HF (1991) Distribution of extracellular tracers in perivascular spaces of the rat brain. Brain Res 545:103–113PubMedCrossRef Ichimura T, Fraser PA, Cserr HF (1991) Distribution of extracellular tracers in perivascular spaces of the rat brain. Brain Res 545:103–113PubMedCrossRef
28.
Zurück zum Zitat Jellinger KA, Lauda F, Attems J (2007) Sporadic cerebral amyloid angiopathy is not a frequent cause of spontaneous brain hemorrhage. Eur J Neurol 14:923–928PubMedCrossRef Jellinger KA, Lauda F, Attems J (2007) Sporadic cerebral amyloid angiopathy is not a frequent cause of spontaneous brain hemorrhage. Eur J Neurol 14:923–928PubMedCrossRef
29.
Zurück zum Zitat Kalaria RN (1996) Cerebral vessels in ageing and Alzheimer’s disease. Pharmacol Ther 72:193–214PubMedCrossRef Kalaria RN (1996) Cerebral vessels in ageing and Alzheimer’s disease. Pharmacol Ther 72:193–214PubMedCrossRef
30.
Zurück zum Zitat Kawarabayashi T, Younkin LH, Saido TC, Shoji M, Ashe KH, Younkin SG (2001) Age-dependent changes in brain, CSF, and plasma amyloid (beta) protein in the Tg2576 transgenic mouse model of Alzheimer’s disease. J Neurosci 21:372–381PubMed Kawarabayashi T, Younkin LH, Saido TC, Shoji M, Ashe KH, Younkin SG (2001) Age-dependent changes in brain, CSF, and plasma amyloid (beta) protein in the Tg2576 transgenic mouse model of Alzheimer’s disease. J Neurosci 21:372–381PubMed
31.
Zurück zum Zitat Kiuchi Y, Isobe Y, Fukushima K (2002) Type IV collagen prevents amyloid beta-protein fibril formation. Life Sci 70:1555–1564PubMedCrossRef Kiuchi Y, Isobe Y, Fukushima K (2002) Type IV collagen prevents amyloid beta-protein fibril formation. Life Sci 70:1555–1564PubMedCrossRef
32.
Zurück zum Zitat Kiuchi Y, Isobe Y, Fukushima K, Kimura M (2002) Disassembly of amyloid beta-protein fibril by basement membrane components. Life Sci 70:2421–2431PubMedCrossRef Kiuchi Y, Isobe Y, Fukushima K, Kimura M (2002) Disassembly of amyloid beta-protein fibril by basement membrane components. Life Sci 70:2421–2431PubMedCrossRef
33.
Zurück zum Zitat Knox SM, Whitelock JM (2006) Perlecan: how does one molecule do so many things? Cell Mol Life Sci 63:2435–2445PubMedCrossRef Knox SM, Whitelock JM (2006) Perlecan: how does one molecule do so many things? Cell Mol Life Sci 63:2435–2445PubMedCrossRef
34.
Zurück zum Zitat Kouznetsova E, Klingner M, Sorger D, Sabri O, Grossmann U, Steinbach J et al (2006) Developmental and amyloid plaque-related changes in cerebral cortical capillaries in transgenic Tg2576 Alzheimer mice. Int J Dev Neurosci 24:187–193PubMedCrossRef Kouznetsova E, Klingner M, Sorger D, Sabri O, Grossmann U, Steinbach J et al (2006) Developmental and amyloid plaque-related changes in cerebral cortical capillaries in transgenic Tg2576 Alzheimer mice. Int J Dev Neurosci 24:187–193PubMedCrossRef
35.
Zurück zum Zitat Krause DL, Muller N (2010) Neuroinflammation, microglia and implications for anti-inflammatory treatment in Alzheimer’s disease. Int J Alzheimers Dis Krause DL, Muller N (2010) Neuroinflammation, microglia and implications for anti-inflammatory treatment in Alzheimer’s disease. Int J Alzheimers Dis
36.
Zurück zum Zitat Martin AJ, Friston KJ, Colebatch JG, Frackowiak RS (1991) Decreases in regional cerebral blood flow with normal aging. J Cereb Blood Flow Metab 11:684–689PubMed Martin AJ, Friston KJ, Colebatch JG, Frackowiak RS (1991) Decreases in regional cerebral blood flow with normal aging. J Cereb Blood Flow Metab 11:684–689PubMed
37.
Zurück zum Zitat Massaad CA, Amin SK, Hu L, Mei Y, Klann E, Pautler RG (2010) Mitochondrial superoxide contributes to blood flow and axonal transport deficits in the Tg2576 mouse model of Alzheimer’s disease. PLoS One 5:e10561PubMedCrossRef Massaad CA, Amin SK, Hu L, Mei Y, Klann E, Pautler RG (2010) Mitochondrial superoxide contributes to blood flow and axonal transport deficits in the Tg2576 mouse model of Alzheimer’s disease. PLoS One 5:e10561PubMedCrossRef
38.
Zurück zum Zitat Mawuenyega KG, Sigurdson W, Ovod V, Munsell L, Kasten T, Morris JC et al (2010) Decreased clearance of CNS beta-amyloid in Alzheimer’s disease. Science 330(6012):1774PubMedCrossRef Mawuenyega KG, Sigurdson W, Ovod V, Munsell L, Kasten T, Morris JC et al (2010) Decreased clearance of CNS beta-amyloid in Alzheimer’s disease. Science 330(6012):1774PubMedCrossRef
39.
Zurück zum Zitat Miao J, Xu F, Davis J, Otte-Holler I, Verbeek MM, Van Nostrand WE (2005) Cerebral microvascular amyloid beta protein deposition induces vascular degeneration and neuroinflammation in transgenic mice expressing human vasculotropic mutant amyloid beta precursor protein. Am J Pathol 167:505–515PubMedCrossRef Miao J, Xu F, Davis J, Otte-Holler I, Verbeek MM, Van Nostrand WE (2005) Cerebral microvascular amyloid beta protein deposition induces vascular degeneration and neuroinflammation in transgenic mice expressing human vasculotropic mutant amyloid beta precursor protein. Am J Pathol 167:505–515PubMedCrossRef
40.
Zurück zum Zitat Miners JS, Ashby E, Van Helmond Z, Chalmers KA, Palmer LE, Love S et al (2008) Angiotensin-converting enzyme (ACE) levels and activity in Alzheimer’s disease, and relationship of perivascular ACE-1 to cerebral amyloid angiopathy. Neuropathol Appl Neurobiol 34:181–193PubMedCrossRef Miners JS, Ashby E, Van Helmond Z, Chalmers KA, Palmer LE, Love S et al (2008) Angiotensin-converting enzyme (ACE) levels and activity in Alzheimer’s disease, and relationship of perivascular ACE-1 to cerebral amyloid angiopathy. Neuropathol Appl Neurobiol 34:181–193PubMedCrossRef
41.
Zurück zum Zitat Miners JS, Baig S, Palmer J, Palmer LE, Kehoe PG, Love S (2008) Aβ-degrading enzymes in Alzheimer’s disease. Brain Pathol 18:240–252PubMedCrossRef Miners JS, Baig S, Palmer J, Palmer LE, Kehoe PG, Love S (2008) Aβ-degrading enzymes in Alzheimer’s disease. Brain Pathol 18:240–252PubMedCrossRef
42.
Zurück zum Zitat Moody DM, Brown WR, Challa VR, Ghazi-Birry HS, Reboussin DM (1997) Cerebral microvascular alterations in aging, leukoaraiosis, and Alzheimer’s disease. Ann NY Acad Sci 826:103–116PubMedCrossRef Moody DM, Brown WR, Challa VR, Ghazi-Birry HS, Reboussin DM (1997) Cerebral microvascular alterations in aging, leukoaraiosis, and Alzheimer’s disease. Ann NY Acad Sci 826:103–116PubMedCrossRef
43.
Zurück zum Zitat Morgan C, Bugueno MP, Garrido J, Inestrosa NC (2002) Laminin affects polymerization, depolymerization and neurotoxicity of Aβ peptide. Peptides 23:1229–1240PubMedCrossRef Morgan C, Bugueno MP, Garrido J, Inestrosa NC (2002) Laminin affects polymerization, depolymerization and neurotoxicity of Aβ peptide. Peptides 23:1229–1240PubMedCrossRef
44.
Zurück zum Zitat Natte R, Maat-Schieman ML, Haan J, Bornebroek M, Roos RA, van Duinen SG (2001) Dementia in hereditary cerebral hemorrhage with amyloidosis-Dutch type is associated with cerebral amyloid angiopathy but is independent of plaques and neurofibrillary tangles. Ann Neurol 50:765–772PubMedCrossRef Natte R, Maat-Schieman ML, Haan J, Bornebroek M, Roos RA, van Duinen SG (2001) Dementia in hereditary cerebral hemorrhage with amyloidosis-Dutch type is associated with cerebral amyloid angiopathy but is independent of plaques and neurofibrillary tangles. Ann Neurol 50:765–772PubMedCrossRef
45.
Zurück zum Zitat Ochi H, Abraham M, Ishikawa H, Frenkel D, Yang K, Basso AS et al (2006) Oral CD3-specific antibody suppresses autoimmune encephalomyelitis by inducing CD4+CD25− LAP + T cells. Nat Med 12:627–635PubMedCrossRef Ochi H, Abraham M, Ishikawa H, Frenkel D, Yang K, Basso AS et al (2006) Oral CD3-specific antibody suppresses autoimmune encephalomyelitis by inducing CD4+CD25− LAP + T cells. Nat Med 12:627–635PubMedCrossRef
46.
Zurück zum Zitat Paris D, Patel N, DelleDonne A, Quadros A, Smeed R, Mullan M (2004) Impaired angiogenesis in a transgenic mouse model of cerebral amyloidosis. Neurosci Lett 366:80–85PubMedCrossRef Paris D, Patel N, DelleDonne A, Quadros A, Smeed R, Mullan M (2004) Impaired angiogenesis in a transgenic mouse model of cerebral amyloidosis. Neurosci Lett 366:80–85PubMedCrossRef
47.
Zurück zum Zitat Park L, Anrather J, Zhou P, Frys K, Pitstick R, Younkin S et al (2005) NADPH-oxidase-derived reactive oxygen species mediate the cerebrovascular dysfunction induced by the amyloid beta peptide. J Neurosci 25:1769–1777PubMedCrossRef Park L, Anrather J, Zhou P, Frys K, Pitstick R, Younkin S et al (2005) NADPH-oxidase-derived reactive oxygen species mediate the cerebrovascular dysfunction induced by the amyloid beta peptide. J Neurosci 25:1769–1777PubMedCrossRef
48.
Zurück zum Zitat Patton RL, Kalback WM, Esh CL, Kokjohn TA, Van Vickle GD, Luehrs DC et al (2006) Amyloid-beta peptide remnants in AN-1792-immunized Alzheimer’s disease patients: a biochemical analysis. Am J Pathol 169:1048–1063PubMedCrossRef Patton RL, Kalback WM, Esh CL, Kokjohn TA, Van Vickle GD, Luehrs DC et al (2006) Amyloid-beta peptide remnants in AN-1792-immunized Alzheimer’s disease patients: a biochemical analysis. Am J Pathol 169:1048–1063PubMedCrossRef
49.
Zurück zum Zitat Perlmutter LS (1994) Microvascular pathology and vascular basement membrane components in Alzheimer’s disease. Mol Neurobiol 9:33–40PubMedCrossRef Perlmutter LS (1994) Microvascular pathology and vascular basement membrane components in Alzheimer’s disease. Mol Neurobiol 9:33–40PubMedCrossRef
50.
Zurück zum Zitat Pfeifer LA, White LR, Ross GW, Petrovitch H, Launer LJ (2002) Cerebral amyloid angiopathy and cognitive function: the HAAS autopsy study. Neurology 58:1629–1634PubMed Pfeifer LA, White LR, Ross GW, Petrovitch H, Launer LJ (2002) Cerebral amyloid angiopathy and cognitive function: the HAAS autopsy study. Neurology 58:1629–1634PubMed
51.
Zurück zum Zitat Pfeifer M, Boncristiano S, Bondolfi L, Stalder A, Deller T, Staufenbiel M et al (2002) Cerebral hemorrhage after passive anti-Aβ immunotherapy. Science 298:1379PubMedCrossRef Pfeifer M, Boncristiano S, Bondolfi L, Stalder A, Deller T, Staufenbiel M et al (2002) Cerebral hemorrhage after passive anti-Aβ immunotherapy. Science 298:1379PubMedCrossRef
52.
Zurück zum Zitat Preston SD, Steart PV, Wilkinson A, Nicoll JA, Weller RO (2003) Capillary and arterial cerebral amyloid angiopathy in Alzheimer’s disease: defining the perivascular route for the elimination of amyloid beta from the human brain. Neuropathol Appl Neurobiol 29:106–117PubMedCrossRef Preston SD, Steart PV, Wilkinson A, Nicoll JA, Weller RO (2003) Capillary and arterial cerebral amyloid angiopathy in Alzheimer’s disease: defining the perivascular route for the elimination of amyloid beta from the human brain. Neuropathol Appl Neurobiol 29:106–117PubMedCrossRef
53.
Zurück zum Zitat Riddle DR, Sonntag WE, Lichtenwalner RJ (2003) Microvascular plasticity in aging. Ageing Res Rev 2:149–168PubMedCrossRef Riddle DR, Sonntag WE, Lichtenwalner RJ (2003) Microvascular plasticity in aging. Ageing Res Rev 2:149–168PubMedCrossRef
54.
Zurück zum Zitat Schley D, Carare-Nnadi R, Please CP, Perry VH, Weller RO (2006) Mechanisms to explain the reverse perivascular transport of solutes out of the brain. J Theor Biol 238:962–974PubMedCrossRef Schley D, Carare-Nnadi R, Please CP, Perry VH, Weller RO (2006) Mechanisms to explain the reverse perivascular transport of solutes out of the brain. J Theor Biol 238:962–974PubMedCrossRef
55.
Zurück zum Zitat Shimizu H, Ghazizadeh M, Sato S, Oguro T, Kawanami O (2009) Interaction between beta-amyloid protein and heparan sulfate proteoglycans from the cerebral capillary basement membrane in Alzheimer’s disease. J Clin Neurosci 16:277–282PubMedCrossRef Shimizu H, Ghazizadeh M, Sato S, Oguro T, Kawanami O (2009) Interaction between beta-amyloid protein and heparan sulfate proteoglycans from the cerebral capillary basement membrane in Alzheimer’s disease. J Clin Neurosci 16:277–282PubMedCrossRef
56.
Zurück zum Zitat Shin HK, Jones PB, Garcia-Alloza M, Borrelli L, Greenberg SM, Bacskai BJ et al (2007) Age-dependent cerebrovascular dysfunction in a transgenic mouse model of cerebral amyloid angiopathy. Brain 130:2310–2319PubMedCrossRef Shin HK, Jones PB, Garcia-Alloza M, Borrelli L, Greenberg SM, Bacskai BJ et al (2007) Age-dependent cerebrovascular dysfunction in a transgenic mouse model of cerebral amyloid angiopathy. Brain 130:2310–2319PubMedCrossRef
57.
Zurück zum Zitat Steffensen B, Chen Z, Pal S, Mikhailova M, Su J, Wang Y et al (2010) Fragmentation of fibronectin by inherent autolytic and matrix metalloproteinase activities. Matrix Biol Steffensen B, Chen Z, Pal S, Mikhailova M, Su J, Wang Y et al (2010) Fragmentation of fibronectin by inherent autolytic and matrix metalloproteinase activities. Matrix Biol
58.
Zurück zum Zitat Szentistvanyi I, Patlak CS, Ellis RA, Cserr HF (1984) Drainage of interstitial fluid from different regions of rat brain. Am J Physiol 246:F835–F844PubMed Szentistvanyi I, Patlak CS, Ellis RA, Cserr HF (1984) Drainage of interstitial fluid from different regions of rat brain. Am J Physiol 246:F835–F844PubMed
59.
Zurück zum Zitat Tchougounova E, Forsberg E, Angelborg G, Kjellen L, Pejler G (2001) Altered processing of fibronectin in mice lacking heparin: a role for heparin-dependent mast cell chymase in fibronectin degradation. J Biol Chem 276:3772–3777PubMedCrossRef Tchougounova E, Forsberg E, Angelborg G, Kjellen L, Pejler G (2001) Altered processing of fibronectin in mice lacking heparin: a role for heparin-dependent mast cell chymase in fibronectin degradation. J Biol Chem 276:3772–3777PubMedCrossRef
60.
Zurück zum Zitat Thal DR, Larionov S, Abramowski D, Wiederhold KH, Van Dooren T, Yamaguchi H et al (2007) Occurrence and co-localization of amyloid beta-protein and apolipoprotein E in perivascular drainage channels of wild-type and APP-transgenic mice. Neurobiol Aging 28:1221–1230PubMedCrossRef Thal DR, Larionov S, Abramowski D, Wiederhold KH, Van Dooren T, Yamaguchi H et al (2007) Occurrence and co-localization of amyloid beta-protein and apolipoprotein E in perivascular drainage channels of wild-type and APP-transgenic mice. Neurobiol Aging 28:1221–1230PubMedCrossRef
61.
Zurück zum Zitat Tian J, Shi J, Smallman R, Iwatsubo T, Mann DM (2006) Relationships in Alzheimer’s disease between the extent of Aβ deposition in cerebral blood vessel walls, as cerebral amyloid angiopathy, and the amount of cerebrovascular smooth muscle cells and collagen. Neuropathol Appl Neurobiol 32:332–340PubMedCrossRef Tian J, Shi J, Smallman R, Iwatsubo T, Mann DM (2006) Relationships in Alzheimer’s disease between the extent of Aβ deposition in cerebral blood vessel walls, as cerebral amyloid angiopathy, and the amount of cerebrovascular smooth muscle cells and collagen. Neuropathol Appl Neurobiol 32:332–340PubMedCrossRef
62.
Zurück zum Zitat Timpl R (1996) Macromolecular organization of basement membranes. Curr Opin Cell Biol 8:618–624PubMedCrossRef Timpl R (1996) Macromolecular organization of basement membranes. Curr Opin Cell Biol 8:618–624PubMedCrossRef
63.
Zurück zum Zitat Topple A, Fifkova E, Cullen-Dockstader K (1990) Effect of age on blood vessels and neurovascular appositions in the rat dentate fascia. Neurobiol Aging 11:371–380PubMedCrossRef Topple A, Fifkova E, Cullen-Dockstader K (1990) Effect of age on blood vessels and neurovascular appositions in the rat dentate fascia. Neurobiol Aging 11:371–380PubMedCrossRef
64.
Zurück zum Zitat Uspenskaia O, Liebetrau M, Herms J, Danek A, Hamann GF (2004) Aging is associated with increased collagen type IV accumulation in the basal lamina of human cerebral microvessels. BMC Neurosci 5:37PubMedCrossRef Uspenskaia O, Liebetrau M, Herms J, Danek A, Hamann GF (2004) Aging is associated with increased collagen type IV accumulation in the basal lamina of human cerebral microvessels. BMC Neurosci 5:37PubMedCrossRef
65.
Zurück zum Zitat Van Dorpe J, Smeijers L, Dewachter I, Nuyens D, Spittaels K, Van Den Haute C et al (2000) Prominent cerebral amyloid angiopathy in transgenic mice overexpressing the London mutant of human APP in neurons. Am J Pathol 157:1283–1298PubMedCrossRef Van Dorpe J, Smeijers L, Dewachter I, Nuyens D, Spittaels K, Van Den Haute C et al (2000) Prominent cerebral amyloid angiopathy in transgenic mice overexpressing the London mutant of human APP in neurons. Am J Pathol 157:1283–1298PubMedCrossRef
66.
Zurück zum Zitat van Horssen J, Kleinnijenhuis J, Maass CN, Rensink AA, Otte-Holler I, David G et al (2002) Accumulation of heparan sulfate proteoglycans in cerebellar senile plaques. Neurobiol Aging 23:537–545PubMedCrossRef van Horssen J, Kleinnijenhuis J, Maass CN, Rensink AA, Otte-Holler I, David G et al (2002) Accumulation of heparan sulfate proteoglycans in cerebellar senile plaques. Neurobiol Aging 23:537–545PubMedCrossRef
67.
Zurück zum Zitat van Horssen J, Otte-Holler I, David G, Maat-Schieman ML, van den Heuvel LP, Wesseling P et al (2001) Heparan sulfate proteoglycan expression in cerebrovascular amyloid beta deposits in Alzheimer’s disease and hereditary cerebral hemorrhage with amyloidosis (Dutch) brains. Acta Neuropathol 102:604–614PubMed van Horssen J, Otte-Holler I, David G, Maat-Schieman ML, van den Heuvel LP, Wesseling P et al (2001) Heparan sulfate proteoglycan expression in cerebrovascular amyloid beta deposits in Alzheimer’s disease and hereditary cerebral hemorrhage with amyloidosis (Dutch) brains. Acta Neuropathol 102:604–614PubMed
68.
Zurück zum Zitat Weller RO, Boche D, Nicoll JA (2009) Microvasculature changes and cerebral amyloid angiopathy in Alzheimer’s disease and their potential impact on therapy. Acta Neuropathol 118:87–102PubMedCrossRef Weller RO, Boche D, Nicoll JA (2009) Microvasculature changes and cerebral amyloid angiopathy in Alzheimer’s disease and their potential impact on therapy. Acta Neuropathol 118:87–102PubMedCrossRef
69.
Zurück zum Zitat Weller RO, Cohen NR, Nicoll JA (2004) Cerebrovascular disease and the pathophysiology of Alzheimer’s disease. Implications for therapy. Panminerva Med 46:239–251PubMed Weller RO, Cohen NR, Nicoll JA (2004) Cerebrovascular disease and the pathophysiology of Alzheimer’s disease. Implications for therapy. Panminerva Med 46:239–251PubMed
70.
Zurück zum Zitat Weller RO, Subash M, Preston SD, Mazanti I, Carare RO (2008) Perivascular drainage of amyloid-beta peptides from the brain and its failure in cerebral amyloid angiopathy and Alzheimer’s disease. Brain Pathol 18:253–266PubMedCrossRef Weller RO, Subash M, Preston SD, Mazanti I, Carare RO (2008) Perivascular drainage of amyloid-beta peptides from the brain and its failure in cerebral amyloid angiopathy and Alzheimer’s disease. Brain Pathol 18:253–266PubMedCrossRef
71.
Zurück zum Zitat Wilcock DM, Rojiani A, Rosenthal A, Subbarao S, Freeman MJ, Gordon MN et al (2004) Passive immunotherapy against Aβ in aged APP-transgenic mice reverses cognitive deficits and depletes parenchymal amyloid deposits in spite of increased vascular amyloid and microhemorrhage. J Neuroinflammation 1:24PubMedCrossRef Wilcock DM, Rojiani A, Rosenthal A, Subbarao S, Freeman MJ, Gordon MN et al (2004) Passive immunotherapy against Aβ in aged APP-transgenic mice reverses cognitive deficits and depletes parenchymal amyloid deposits in spite of increased vascular amyloid and microhemorrhage. J Neuroinflammation 1:24PubMedCrossRef
72.
Zurück zum Zitat Wyss-Coray T, Lin C, Sanan DA, Mucke L, Masliah E (2000) Chronic overproduction of transforming growth factor-beta1 by astrocytes promotes Alzheimer’s disease-like microvascular degeneration in transgenic mice. Am J Pathol 156:139–150PubMedCrossRef Wyss-Coray T, Lin C, Sanan DA, Mucke L, Masliah E (2000) Chronic overproduction of transforming growth factor-beta1 by astrocytes promotes Alzheimer’s disease-like microvascular degeneration in transgenic mice. Am J Pathol 156:139–150PubMedCrossRef
Metadaten
Titel
Perivascular drainage of solutes is impaired in the ageing mouse brain and in the presence of cerebral amyloid angiopathy
verfasst von
Cheryl A. Hawkes
Wolfgang Härtig
Johannes Kacza
Reinhard Schliebs
Roy O. Weller
James A. Nicoll
Roxana O. Carare
Publikationsdatum
01.04.2011
Verlag
Springer-Verlag
Erschienen in
Acta Neuropathologica / Ausgabe 4/2011
Print ISSN: 0001-6322
Elektronische ISSN: 1432-0533
DOI
https://doi.org/10.1007/s00401-011-0801-7

Weitere Artikel der Ausgabe 4/2011

Acta Neuropathologica 4/2011 Zur Ausgabe

Leitlinien kompakt für die Neurologie

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Neurologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.